Real-time PCR and Digital PCR Market

Digital PCR (Digital PCR-dPCR) technology is a new method for nucleic acid detection and quantification. Unlike traditional quantitative PCR (qPCR) technology, digital PCR uses absolute quantification and does not rely on standard curves and reference samples to directly detect targets The copy number of the sequence. Because this detection method has better sensitivity, specificity and accuracy than traditional qPCR, dPCR has been widely used quickly. This technology is used in the detection of very small amounts of nucleic acid samples, detection of rare mutations in complex backgrounds and identification of small differences in expression levels. The realized advantages have been widely recognized, and its many advantages in gene expression research, microRNA research, genome copy number identification, rare mutation detection of cancer markers, identification of pathogenic microorganisms, identification of transgenic components, accurate quantification of NGS sequencing libraries, and result verification, etc. The broad application prospects it has already received more and more attention.

Real-time PCR and Digital PCR Market contains market size and forecasts of Real-time PCR (qPCR) and Digital PCR (dPCR) in Global, including the following market information:

• Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Real-time PCR (qPCR) and Digital PCR (dPCR) market was valued at 2889.8 million in 2021 and is projected to reach US$ 4353.6 million by 2028, at a CAGR of 6.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Digital Microfluidic Chip PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Real-time PCR (qPCR) and Digital PCR (dPCR) include Thermo Fisher and Bio-rad etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Real-time PCR (qPCR) and Digital PCR (dPCR) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Segment Percentages, by Type, 2021 (%)

• Digital Microfluidic Chip PCR
• Droplet Digital PCR

Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Segment Percentages, by Application, 2021 (%)

• Medical Institutions
• Universities and Research Institutes
• Government
• Other

Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Real-time PCR (qPCR) and Digital PCR (dPCR) revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Real-time PCR (qPCR) and Digital PCR (dPCR) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher
• Bio-rad